Received Oct 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Injection site pain,j ust received flu, rsv, shingles, pneumonia and is really sore; This non-serious case was reported by a consumer via other manufacturer and described the occurrence of injection site pain in a 64-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis, INFLUENZA VACCINE for prophylaxis and PNEUMOCOCCAL VACCINE for prophylaxis. Previously administered products included Dupixent with an associated reaction of pain (On 27-FEB-2024 the patient developed event it hurts). In AUG-2025, the patient received Shingles vaccine, RSV vaccine, INFLUENZA VACCINE and PNEUMOCOCCAL VACCINE. On an unknown date, an unknown time after receiving Shingles vaccine, RSV vaccine, INFLUENZA VACCINE and PNEUMOCOCCAL VACCINE, the patient experienced injection site pain (Verbatim: Injection site pain,j ust received flu, rsv, shingles, pneumonia and is really sore). The outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine, RSV vaccine, INFLUENZA VACCINE and PNEUMOCOCCAL VACCINE. It was unknown if the company considered the injection site pain to be related to Shingles vaccine, RSV vaccine, INFLUENZA VACCINE and PNEUMOCOCCAL VACCINE. Additional Information: GSK Receipt Date: 12-SEP-2025 In Aug-2025, the patient received a dose of suspect Influenza Vaccine, Respiratory Syncytial Virus Vaccine, Shingles vaccine and Pneumococcal Vaccine (formulation, dose, route, indication: unknown). In Aug-2025, the patient developed a non-serious event just received flu, RSV, shingles, pneumonia and is really sore (vaccination site pain) (latency: approximately 1 year, 11 months, 2 weeks with Dupilumab; same day with rest of the suspects) following the first dose intake (unknown batch number and expiry date for all suspects) of D UPILU MAB, Influenza Vaccine, Respiratory Syncytial Virus Vaccine, Shingles vaccine and Pneumococcal Vaccine.
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: DUPIXENT